ArticleBMJ public health2026
Socioeconomic consequences of tuberculosis for households in Nigeria: a longitudinal patient cost survey within an intervention engaging informal health providers.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB) imposes a significant economic and social burden on affected households, particularly in low- and middle-income country settings. In Nigeria, many people with TB first seek care from informal healthcare providers. This study assessed the economic and social consequences of TB among patients referred by informal providers in Northeast Nigeria. Methods: A longitudinal patient cost survey was conducted alongside a case-finding intervention engaging informal providers in Adamawa and Yobe states between July and December 2022 among adults with drug-susceptible pulmonary TB referred by traditional healers or patent and proprietary medicine vendors. Participants (n=195) were interviewed at three time points during treatment to collect data on direct and indirect costs, household income and other socioeconomic consequences. Results: The mean total cost of a TB episode was US$187 (95% CI 170 to 203), with direct costs accounting for 68% of total expenditures. Despite lower average costs compared with national estimates, 27% (n=52) of households incurred catastrophic costs. Food insecurity was reported by 62% (n=122) of households during treatment. Lower pre-TB household income was strongly associated with incurrence of catastrophic costs and adverse social outcomes, including job loss and stigma. Conclusions: Engaging informal providers in TB referral may contribute to lower patient costs compared with national estimates but substantial economic and social consequences remain. Strengthening social protection measures is needed to mitigate the broader socioeconomic impact of TB, particularly among vulnerable households.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.